This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of kinase inhibitors. It serves as a key intermediate or active pharmaceutical ingredient (API) in the synthesis of drugs targeting specific kinases involved in various diseases, including cancer and inflammatory disorders. Its structural features, such as the cyclopropyl and methylsulfonamido groups, contribute to its ability to bind effectively to kinase domains, making it a valuable candidate for therapeutic applications. Researchers also explore its potential in optimizing drug efficacy and selectivity for targeted therapies.